Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide

Abstract

ImportanceIn recent decades, there has been increased interest in the possible adverse neurological effects of 5α-reductase inhibitors (5-ARIs), which have been used mainly for benign prostatic hyperplasia and androgenic alopecia. Numerous studies and reports have indicated associations of 5-ARIs with depression and suicide. However, most of these studies had methodological shortcomings, and very little is known about the potential association of 5-ARIs with dementia.ObjectiveTo investigate the association of 5-ARI use with all-cause dementia, Alzheimer disease, vascular dementia, depression, and suicide.Design, Setting, and ParticipantsThis Swedish register-based cohort study included 2 236 876 men aged 50 to 90 years between July 1, 2005, and December 31, 2018. Statistical analyses were performed from September 15, 2021, to May 25, 2022.Main Outcomes and MeasuresA diagnosis of all-cause dementia, Alzheimer disease, vascular dementia, depression, or completed suicide.ExposuresA recorded prescription in the Swedish national prescription register of finasteride or dutasteride and duration of use.ResultsOf 2 236 876 men (median age at the start of follow-up, 55 years [IQR, 50-65 years] and at treatment initiation, 73 years [IQR, 66-80 years]), 70 645 (3.2%) started finasteride treatment, and 8774 (0.4%) started dutasteride treatment. Men taking finasteride or dutasteride were at increased risk of all-cause dementia (finasteride: hazard ratio [HR], 1.22 [95% CI, 1.17-1.28]; dutasteride: HR, 1.10 [95% CI, 1.01-1.20]), Alzheimer disease (finasteride: HR, 1.20 [95% CI, 1.10-1.31]; dutasteride: HR, 1.28 [95% CI, 1.09-1.50]), vascular dementia (finasteride: HR, 1.44 [95% CI, 1.30-1.58]; dutasteride: HR, 1.31 [95% CI, 1.08-1.59]), and depression (finasteride: HR, 1.61 [95% CI, 1.48-1.75]; dutasteride: HR, 1.68 [95% CI, 1.43-1.96]). However, the magnitude of the association decreased over time, and the findings became statistically nonsignificant with continuous exposures over 4 years, except for depression, which showed a constant risk over time, with no differences between finasteride and dutasteride. In contrast, 5-ARIs were not associated with suicide (finasteride: HR, 1.22 [95% CI, 0.99-1.49]; dutasteride: HR, 0.98 [95% CI, 0.62-1.54]).Conclusions and RelevanceThis cohort study found that, while men receiving 5-ARI treatment showed a higher risk for dementia in the initial periods after starting treatment, the decreasing magnitude of the association over time suggested that the risk may be, entirely or in part, due to increased dementia detection among patients with benign prostate enlargement. Both finasteride and dutasteride were similarly associated with depression with a constant risk over time, while neither drug was associated with suicide. Prescribing clinicians and potential users should be aware of the possible risks for depression associated with 5-ARI use.

Implicações do uso do Metilfenidato no tratamento do Transtorno de Déficit de Atenção e Hiperatividade

“…Especula-se que o metilfenidato possa aumentar a neurotransmissão de catecolaminas, ativando os adrenoceptores β1 cardiovasculares, predispondo a uma variedade de eventos cardiovasculares, incluindo arritmias, infarto do miocárdio e morte cardíaca. Apesar dessas descobertas, o estudo enfatiza que isso não deve ser motivo para interromper o tratamento e destaca a importância de uma avaliação individualizada do risco-benefício (Garcia-Argibay et al, 2024).…”

Impaired Arginine Metabolism in Hair Follicles: A Potential Mechanism in Androgenetic Alopecia

“…The current prevailing theories regarding the mechanism of hair miniaturization in AGA suggest that it is a hereditary condition caused by aberrant androgen sensitivity and activity 9,10 . However, the clinical effectiveness of anti-androgen therapy, such as the oral administration of nasteride and spironolactone, is limited, particularly in cases of moderate to severe AGA, coupled with several unexpected side effect [11][12][13] . Consequently, numerous studies are currently endeavoring to elucidate the potential pathogenic mechanism underlying AGA from alternative viewpoints.…”